Too Much Information?

USA Today takes a look at the rapid uptake of chromosomal microarrays for prenatal testing, noting that while the approach can detect more genetic abnormalities than current methods like karyotyping, the significance of many of these variants is often unknown.

"Our capacity to test and our capacity to make sense of the results are not well-aligned," Rachel Grob, the author of a book on prenatal and neonatal genetic testing, tells the paper.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.